Skip to content
DraconiticResearch
Search Sources API
197,785 studies31 sourcesUpdated 14 min ago
PreprintAll rights reservedbioRxiv

CD300a Blockade attenuates renal fibrosis by enhancing macrophage efferocytosis and neutrophil MMP9 production

  1. 1University of Tsukuba

Related

  1. Modulating macrophage efferocytosis: Drug delivery strategies for enhancement, mimicry, and inhibition.
    Zhihua Liu, Jiahui Wu, Jiayan Lyu +2
    Acta pharmaceutica Sinica. BPeer-reviewedCC BY-NC-NDFull textImmunologyEurope PMCPMC
  2. Fragmented uptake drives lipid accumulation in macrophage cannibalistic efferocytosis
    Keith L. Chambers
    arXivPreprintCC BY-NC-ND 4.0Full textCell biologyarXiv
  3. The Efferocytosis-Driven Macrophage Polarization: A Concerto in the Tumor Immunosuppressive Microenvironment.
    Qiuping Chen, Chunzhi Wu, Changquan Huang +1
    MedCommPeer-reviewedCC BYFull textImmunologyEurope PMC
  4. Macrophage efferocytosis in MASH: balancing inflammation resolution and fibrosis
    Qian Liu, Yongcheng Yang
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref
  5. Metabolic stress and macrophage efferocytosis in osteoarthritis: mechanisms and therapeutic implications
    HaoYang Wu, DeChao Yuan, RenJian He +1
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyPMCCrossrefEurope PMC
BibTeX
@misc{lee2026cd300a,
  title = {{CD300a Blockade attenuates renal fibrosis by enhancing macrophage efferocytosis and neutrophil MMP9 production}},
  author = {J. Lee and C. Nakahashi-Oda and H. Koizumi and F. Abe and K. Shibuya and A. Shibuya},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.25.754396},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.25.754396v1},
}
RIS
TY  - UNPB
TI  - CD300a Blockade attenuates renal fibrosis by enhancing macrophage efferocytosis and neutrophil MMP9 production
AU  - J. Lee
AU  - C. Nakahashi-Oda
AU  - H. Koizumi
AU  - F. Abe
AU  - K. Shibuya
AU  - A. Shibuya
PY  - 2026
DA  - 2026/09/25
PB  - bioRxiv
DO  - 10.64898/2026.09.25.754396
UR  - https://www.biorxiv.org/content/10.64898/2026.09.25.754396v1
ER  -